Trial intelligence / Profile preview

Tinidazole versus placebo for chronic cough associated with Lophomonas blattarum

IRCT20091111002695N10Phase 3Completed

Sponsor
Islamic Azad University
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tinidazole in lophomoniasis and chronic cough (2 arms), sponsored by Islamic Azad University. Primary endpoints: Cough grading, Sputum and 8 more. Started Dec 2020; status: completed.

02

Drugs

tinidazole
03

Conditions

lophomoniasischronic cough

Beyond the preview

Go deeper on IRCT20091111002695N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20091111002695N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call